Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Red Violet, Inc.
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-81.1% vs price
Base Case (Median)
-73.5% vs price
Bull Case (75th pct.)
-48.9% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $16.02 | -79.5% | High (40%) |
| PE Comparable | $29.50 | -62.2% | Medium (25%) |
| Growth Trajectory DCF | $64.55 | -17.3% | Medium (20%) |
| Graham Number | $13.45 | -82.8% | Low (10%) |
| EV/EBITDA | $20.67 | -73.5% | Medium (20%) |
| EV/FCF | $50.29 | -35.6% | Medium (20%) |
| Earnings Power Value | $6.24 | -92.0% | Medium (50%) |
Based on 7 out of 7 methods, RDVT appears overvalued at the current price of $78.09. The base case fair value of $20.67 implies 73.5% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.